Evotec Equity Investments
Corporate venture profile
Evotec Equity Investments is the corporate venture arm of Evotec, a pharmaceutical and biotech company. It is based in Hamburg, Germany. It invests at the Series B stage. Sectors it names: biotech and life sciences.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series B to Series B |
| Sectors | Biotech and life sciences |
| Geography | Europe |
| Offices | Hamburg, Germany |
Sources: S1 Evotec: makes strategic equity investment in Tubulis (participates in Series B).
Data behind this graphic
| Item | Companies | Share |
|---|---|---|
| Exited | 1 | 50% |
| Active | 1 | 50% |
Status as the firm tags it
Sources: S1 Evotec: makes strategic equity investment in Tubulis (participates in Series B).
Where it invests
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Evotec (NASDAQ: EVO; Frankfurt: EVT) | Single source | S1 |
| Parent industry | Pharmaceuticals and biotech | Single source | S1 |
| Headquarters | Hamburg, Germany | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Stages | Series B (inferred from announced rounds) | Estimate | S1 |
About Evotec
Recent rounds
| Date | Company | Round | Amount | Led by the firm | Source |
|---|---|---|---|---|---|
| 2022-05-03 | Tubulis | Series B | EUR 60M | No | S1 |
Portfolio
Portfolio companies named in public sources: Tubulis, Aeovian Pharmaceuticals.S1
| Tag | Companies | Share |
|---|---|---|
| Exited | 1 | 50% |
| Active | 1 | 50% |
Official pages
Read the firm's own pages for current information.
- Website www.evotec.com/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Evotec Equity Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.